Literature DB >> 7517883

Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase.

F Squadrito1, G Calapai, D Altavilla, D Cucinotta, B Zingarelli, V Arcoraci, G M Campo, A P Caputi.   

Abstract

The effects of NG-nitro-L-arginine, an inhibitor of brain nitric oxide (NO) synthase, on central serotoninergic system were studied in male obese Zucker rats and in their lean age-matched controls (FA/?; FA/FA), both groups aged 14 weeks. Acute injection of NG-nitro-L-arginine (50 mg/kg i.p.) or repeated administration of NG-nitro-L-arginine (50 mg/kg i.p. daily, for 7 days) reduced food intake and body weight in obese rats. Acute administration of NG-nitro-L-arginine reduced food intake in lean rats. However, lean rats showed tolerance to the NG-nitro-L-arginine effects after repeated administration. NG-Nitro-L-arginine administration significantly increased serotonin metabolism in the cortex, diencephalon and medulla-pons of obese Zucker rats after either acute or repeated administration of NG-nitro-L-arginine. In contrast, NG-nitro-L-arginine increased serotonin metabolism in lean rats only after acute administration, and the appearance of tolerance to NG-nitro-L-arginine anorectic effects paralleled the failure of NG-nitro-L-arginine to increase serotonin metabolism. The present data extend our previous findings indicating that NG-nitro-L-arginine possesses anorectic activity in obese Zucker rats, and clearly suggest that the central serotoninergic system mediates the anorexia induced by inhibitors of brain NO synthase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517883     DOI: 10.1016/0014-2999(94)90081-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

2.  Inhibitory effect of nitric oxide on neuronal activity in the periaqueductal grey matter of the rat.

Authors:  T A Lovick; B J Key
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

3.  Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis.

Authors:  G Calapai; F Corica; A Corsonello; L Sautebin; M Di Rosa; G M Campo; M Buemi; V N Mauro; A P Caputi
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  Inhibition of nitric oxide formation reduces voluntary ethanol consumption in the rat.

Authors:  G Calapai; G Mazzaglia; L Sautebin; G Costantino; M C Marciano; S Cuzzocrea; M Di Rosa; A P Caputi
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

Review 5.  Regulation of obesity and insulin resistance by nitric oxide.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

6.  The intestinal peptide transporter PEPT1 is involved in food intake regulation in mice fed a high-protein diet.

Authors:  Anna-Maria Nässl; Isabel Rubio-Aliaga; Manuela Sailer; Hannelore Daniel
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

7.  L-arginine abolishes the hypothalamic serotonergic activation induced by central interleukin-1β administration to normal rats.

Authors:  Anderson Iuras; Mônica M Telles; Iracema S Andrade; Gianni M S Santos; Lila M Oyama; Cláudia M O Nascimento; Vera L F Silveira; Eliane B Ribeiro
Journal:  J Neuroinflammation       Date:  2013-12-07       Impact factor: 8.322

8.  Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis.

Authors:  Lorena Avila-Carrasco; Mario A Pavone; Elena González; Álvaro Aguilera-Baca; Rafael Selgas; Gloria Del Peso; Secundino Cigarran; Manuel López-Cabrera; Abelardo Aguilera
Journal:  Front Physiol       Date:  2019-05-28       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.